CAR-T细胞制造景观-过去十年的教训和早期临床发展的考虑
Juliana Dias1,2, John Garcia1,2, Giulia Agliardi1,2
1Centre for Cell, Gene and Tissue Therapeutics, Royal Free Hospital NHS Foundation Trust, London NW3 2QG, UK.
Molecular therapy. Methods & clinical development
|May 13, 2024
概括
尽管在治疗血液癌症方面取得了成功,但化学抗原受体T细胞 (CAR-T) 疗法制造面临着挑战. 本综述探讨了扩大CAR-T细胞疗法的生产障碍和技术进步.
科学领域:
- 细胞免疫疗法细胞免疫疗法
- 生物技术是生物技术.
- 血液瘤学 血液瘤学
背景情况:
- 卡特-T细胞疗法是血液癌症化疗的成功替代方案.
- 对CAR-T细胞疗法的需求增加是由商业批准和众多临床试验推动的.
- 制造能力是广泛采用CAR-T细胞疗法的关键瓶.
研究的目的:
- 审查目前CAR-T细胞制造的情况.
- 确定限制全球生产能力的挑战.
- 讨论技术发展和将新的CAR-T细胞产品转化为临床用途.
主要方法:
- 审查当前的CAR-T细胞制造平台和技术.
- 分析从早期发展到工业水平扩大生产的挑战.
- 讨论质量控制和监管方面的考虑.
- 探索学术团队的临床到临床管道策略.
主要成果:
- 良好的制造实践 (GMP) 平台的重大技术进步正在使复杂的CAR-T细胞产品成为可能.
- 在将科学创新转化为可扩展的临床制造方面,仍然存在挑战.
- 简化工作流程和有效的管道管理对于学术机构提供多样化的CAR-T细胞试验至关重要.
结论:
- 解决制造瓶对于满足对CAR-T细胞疗法的日益增长的需求至关重要.
- 制造技术和工艺优化的持续创新是必要的.
- 成功的翻译需要强大的质量控制和可扩展的生产策略.
相关概念视频
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...